loading page

Cardiac Surgery in the time of the Novel Coronavirus: Why we should think to a new normal
  • +5
  • Gabriele Tamagnini,
  • Raoul Biondi,
  • Gabriella Ricciardi,
  • Roberta Rutigliano,
  • Sergi Trias-Llimós,
  • Bart Meuris,
  • Joseph Lamelas,
  • Mauro Del Giglio
Gabriele Tamagnini
Villa Torri Hospital

Corresponding Author:[email protected]

Author Profile
Raoul Biondi
Villa Torri Hospital
Author Profile
Gabriella Ricciardi
Leiden Universitair Medisch Centrum
Author Profile
Roberta Rutigliano
University of Groningen Faculty of Spatial Sciences
Author Profile
Sergi Trias-Llimós
London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health
Author Profile
Bart Meuris
KUL UZ Gasthuisberg
Author Profile
Joseph Lamelas
University of Miami Miller School of Medicine
Author Profile
Mauro Del Giglio
Villa Torri Hospital
Author Profile


On March 11, 2020, the World Health Organization (WHO) declared the SARS-CoV-2 outbreak a pandemic: it took a toll of more than 300.000 deaths and more than 4.5 million cases, worldwide. The initial data pointed out the tight bond between cardiovascular diseases and worse outcomes in COVID19-patients. Epidemiologically speaking, there is an overlap between the age-groups more affected by COVID-related death and the age-groups in which Cardiac Surgery has its usual base of patients. The Cardiac Surgery Departments have to think to a new normal: since the virus will remain endemic in the society, dedicated pathways or even dedicated Teams are pivotal to treat safely the patients, in respect of the safety of the health care workers. Moreover, we need a keen eye on deciding which pathologies have to be treated with priority: Coronary Artery Disease (CAD) showed a higher mortality rate in patients affected by COVID19, but it’s however reasonable to think that all the cardiac pathologies affecting the lung circulation - such as symptomatic severe mitral diseases or aortic stenosis - might deserve a priority access to treatment, in order to increase the survival rate in case of an acquired-Coronavirus infection later on.
17 May 2020Submitted to Journal of Cardiac Surgery
18 May 2020Submission Checks Completed
18 May 2020Assigned to Editor
18 May 2020Reviewer(s) Assigned
23 May 2020Review(s) Completed, Editorial Evaluation Pending
23 May 2020Editorial Decision: Revise Minor
25 May 20201st Revision Received
27 May 2020Assigned to Editor
27 May 2020Submission Checks Completed
27 May 2020Reviewer(s) Assigned
27 May 2020Review(s) Completed, Editorial Evaluation Pending
27 May 2020Editorial Decision: Revise Minor
28 May 20202nd Revision Received
29 May 2020Submission Checks Completed
29 May 2020Assigned to Editor
29 May 2020Reviewer(s) Assigned
29 May 2020Review(s) Completed, Editorial Evaluation Pending
29 May 2020Editorial Decision: Accept
Aug 2020Published in Journal of Cardiac Surgery volume 35 issue 8 on pages 1761-1764. 10.1111/jocs.14741